Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer

Carcinoembryonic antigen (CEA) is widely used to evaluate the effectiveness of treatment in patients with rectal cancer.The aim of the study was to investigate whether the CEA levels measured before and after neoadjuvant chemoradiotherapy (nCRT) can be used to predict pathological complete response...

Full description

Bibliographic Details
Main Authors: N. V. Severskaya, D. V. Erygin, Yu. V. Aleksandrov, N. G. Minaeva, N. Yu. Dvinskikh, N. Yu. Novikov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2018-11-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/859
_version_ 1826563749033541632
author N. V. Severskaya
D. V. Erygin
Yu. V. Aleksandrov
N. G. Minaeva
N. Yu. Dvinskikh
N. Yu. Novikov
author_facet N. V. Severskaya
D. V. Erygin
Yu. V. Aleksandrov
N. G. Minaeva
N. Yu. Dvinskikh
N. Yu. Novikov
author_sort N. V. Severskaya
collection DOAJ
description Carcinoembryonic antigen (CEA) is widely used to evaluate the effectiveness of treatment in patients with rectal cancer.The aim of the study was to investigate whether the CEA levels measured before and after neoadjuvant chemoradiotherapy (nCRT) can be used to predict pathological complete response (pCR) in patients with locally advanced rectal cancer.Material and methods. 179 patients with locally advanced rectal cancer were treated with nCRT followed by surgical treatment. The serum CEA level was measured before and 610 weeks after the completion of nCRT. Preand post nCRT CEA levels were compared with pCR. The factors associated with pCR were studied.Results. pCR after nCRT was achieved in 12 % (22/179) patients. The incidence of pCR was higher in patients with normal (<5 ng/mL) pre-treatment CEA level (20 % vs 8 %, p=0.019). In patients with the elevated pre-treatment CEA level (> 5 ng/mL), there were no significant differences in the incidence of pCR between cases with normalization and without normalization of CEA level after treatment (p=0.08). The maximum likelihood of pCR determined by the ROC curve was <2.8 ng/mL with pre-treatment CEA (31 %) and <1.8 ng/mL with post-treatment CEA (23 %). Well differentiated tumors (G1) had higher likelihood of pCR (46%) in patients with low pre-treatment CEA (<2.8 ng/mL).Conclusion. Low CEA before and after nCRT is a predictor of pCR. Well differentiated tumors increase the probability of pCR after nCRT.
first_indexed 2024-04-10T01:53:43Z
format Article
id doaj.art-d702722b7ee3467982524b2636ef771b
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2025-03-14T10:08:54Z
publishDate 2018-11-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-d702722b7ee3467982524b2636ef771b2025-03-02T11:16:10ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682018-11-01175606610.21294/1814-4861-2018-17-5-60-66577Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancerN. V. Severskaya0D. V. Erygin1Yu. V. Aleksandrov2N. G. Minaeva3N. Yu. Dvinskikh4N. Yu. Novikov5National Medical Research Radiological Center of the Ministry of Health of the Russian FederationNational Medical Research Radiological Center of the Ministry of Health of the Russian FederationNational Medical Research Radiological Center of the Ministry of Health of the Russian FederationNational Medical Research Radiological Center of the Ministry of Health of the Russian FederationNational Medical Research Radiological Center of the Ministry of Health of the Russian FederationNational Medical Research Radiological Center of the Ministry of Health of the Russian FederationCarcinoembryonic antigen (CEA) is widely used to evaluate the effectiveness of treatment in patients with rectal cancer.The aim of the study was to investigate whether the CEA levels measured before and after neoadjuvant chemoradiotherapy (nCRT) can be used to predict pathological complete response (pCR) in patients with locally advanced rectal cancer.Material and methods. 179 patients with locally advanced rectal cancer were treated with nCRT followed by surgical treatment. The serum CEA level was measured before and 610 weeks after the completion of nCRT. Preand post nCRT CEA levels were compared with pCR. The factors associated with pCR were studied.Results. pCR after nCRT was achieved in 12 % (22/179) patients. The incidence of pCR was higher in patients with normal (<5 ng/mL) pre-treatment CEA level (20 % vs 8 %, p=0.019). In patients with the elevated pre-treatment CEA level (> 5 ng/mL), there were no significant differences in the incidence of pCR between cases with normalization and without normalization of CEA level after treatment (p=0.08). The maximum likelihood of pCR determined by the ROC curve was <2.8 ng/mL with pre-treatment CEA (31 %) and <1.8 ng/mL with post-treatment CEA (23 %). Well differentiated tumors (G1) had higher likelihood of pCR (46%) in patients with low pre-treatment CEA (<2.8 ng/mL).Conclusion. Low CEA before and after nCRT is a predictor of pCR. Well differentiated tumors increase the probability of pCR after nCRT.https://www.siboncoj.ru/jour/article/view/859rectal cancerceatumor regression gradepathological complete responseneo-adjuvant chemoradiotherapy
spellingShingle N. V. Severskaya
D. V. Erygin
Yu. V. Aleksandrov
N. G. Minaeva
N. Yu. Dvinskikh
N. Yu. Novikov
Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
Сибирский онкологический журнал
rectal cancer
cea
tumor regression grade
pathological complete response
neo-adjuvant chemoradiotherapy
title Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
title_full Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
title_fullStr Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
title_full_unstemmed Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
title_short Carcinoembryonic antigen BEFORE AND AFTER neoadjuvant chemoradiotherapy IN PREDICTION OF pathological complete response in patients with locally advanced rectal cancer
title_sort carcinoembryonic antigen before and after neoadjuvant chemoradiotherapy in prediction of pathological complete response in patients with locally advanced rectal cancer
topic rectal cancer
cea
tumor regression grade
pathological complete response
neo-adjuvant chemoradiotherapy
url https://www.siboncoj.ru/jour/article/view/859
work_keys_str_mv AT nvseverskaya carcinoembryonicantigenbeforeandafterneoadjuvantchemoradiotherapyinpredictionofpathologicalcompleteresponseinpatientswithlocallyadvancedrectalcancer
AT dverygin carcinoembryonicantigenbeforeandafterneoadjuvantchemoradiotherapyinpredictionofpathologicalcompleteresponseinpatientswithlocallyadvancedrectalcancer
AT yuvaleksandrov carcinoembryonicantigenbeforeandafterneoadjuvantchemoradiotherapyinpredictionofpathologicalcompleteresponseinpatientswithlocallyadvancedrectalcancer
AT ngminaeva carcinoembryonicantigenbeforeandafterneoadjuvantchemoradiotherapyinpredictionofpathologicalcompleteresponseinpatientswithlocallyadvancedrectalcancer
AT nyudvinskikh carcinoembryonicantigenbeforeandafterneoadjuvantchemoradiotherapyinpredictionofpathologicalcompleteresponseinpatientswithlocallyadvancedrectalcancer
AT nyunovikov carcinoembryonicantigenbeforeandafterneoadjuvantchemoradiotherapyinpredictionofpathologicalcompleteresponseinpatientswithlocallyadvancedrectalcancer